Procure-to-pay (P2P) workflows in biotech and pharma are significantly more complex than traditional corporate purchasing processes. Research organizations must coordinate scientific purchasing, supplier management, finance controls, compliance documentation, and inventory planning across fragmented supplier ecosystems.
Improving P2P performance is not simply about processing purchase orders faster; it directly affects research continuity, budget visibility, audit readiness, and operational efficiency across R&D and finance teams.
This guide explores operational best practices for improving P2P workflows in life sciences and reducing the procurement bottlenecks that commonly slow research organizations.
For an overview of how the procure-to-pay lifecycle works in biotech and pharma organizations, see our guide to procure-to-pay in life sciences.
Many procurement systems were originally designed for standardized enterprise purchasing environments, but life sciences organizations operate differently.
Many organizations struggling with fragmented supplier ecosystems eventually prioritize centralized sourcing and supplier consolidation strategies to improve visibility and operational control.
Research-driven environments frequently experience recurring inefficiencies that reduce visibility and create delays across both procurement and scientific operations.
To transition procurement from a reactive function to a strategic advantage, organizations typically adopt these best practices:
ERP systems play an important role in financial governance by supporting invoice processing, payment workflows, general ledger controls, and financial reporting.
However, sourcing workflows, supplier comparison, and scientific purchasing frequently occur outside the ERP layer. This creates operational gaps between procurement execution and financial systems.
As a result, many biotech and pharma organizations integrate procurement orchestration and supplier management platforms alongside ERP infrastructure to improve workflow coordination and strengthen ERP and procurement integrations across sourcing and finance systems.
While ERP systems provide essential financial governance like accounts payable and general ledger controls, scientific sourcing and supplier comparison often occur outside the ERP layer. Many organizations integrate procurement orchestration platforms alongside ERP infrastructure to bridge this gap.
To measure the success of these optimizations, procurement leaders should monitor the following KPIs:
Modern procurement platforms increasingly use automation and AI-assisted workflows to improve approval routing, invoice processing, supplier coordination, and spend visibility across procurement operations.
In life sciences environments, these capabilities help procurement teams reduce administrative burden while improving purchasing consistency and operational forecasting across research workflows.
As procurement environments become more complex, organizations are increasingly exploring workflow orchestration and automation technologies that improve sourcing visibility and strengthen procurement coordination across research operations.
What are P2P best practices in biotech and pharma?
P2P best practices include automating approval workflows, improving spend visibility, reducing supplier fragmentation, and standardizing invoice reconciliation.
Why is P2P more complex in life sciences?
It involves specialized suppliers, regulated workflows, scientific exceptions, and fragmented sourcing environments that exceed standard corporate purchasing complexity.
What are common P2P bottlenecks in biotech?
Common issues include approval delays, manual invoice matching, supplier onboarding inefficiencies, and limited spend visibility.
How do ERP systems support P2P workflows?
ERP systems manage financial controls and payments, while sourcing and supplier coordination are often handled through specialized procurement orchestration platforms.